CD8A and hepatocellular carcinoma: Although the targeted antigens (including TAAs, neoantigens, and viral antigens) of these exhausted CD8+ T cells remain elusive this finding provides a mechanistic explanation of the durable objective response to PD-1 checkpoint blockade therapy of at least some patients with advanced HCC [32,107].